ATE171618T1 - Pharmazeutische zusammensetzungen enthaltend dinoreburnamenine derivaten - Google Patents

Pharmazeutische zusammensetzungen enthaltend dinoreburnamenine derivaten

Info

Publication number
ATE171618T1
ATE171618T1 AT96400419T AT96400419T ATE171618T1 AT E171618 T1 ATE171618 T1 AT E171618T1 AT 96400419 T AT96400419 T AT 96400419T AT 96400419 T AT96400419 T AT 96400419T AT E171618 T1 ATE171618 T1 AT E171618T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
dinoreburnamenine
derivatives
alkyl
Prior art date
Application number
AT96400419T
Other languages
English (en)
Inventor
Philippe Becourt
Jean-Luc Dubois
Pierre Metziger
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of ATE171618T1 publication Critical patent/ATE171618T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT96400419T 1995-03-03 1996-02-28 Pharmazeutische zusammensetzungen enthaltend dinoreburnamenine derivaten ATE171618T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9502482A FR2731154B1 (fr) 1995-03-03 1995-03-03 Compositions pharmaceutiques comprenant des derives de dinoreburnamenine

Publications (1)

Publication Number Publication Date
ATE171618T1 true ATE171618T1 (de) 1998-10-15

Family

ID=9476702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96400419T ATE171618T1 (de) 1995-03-03 1996-02-28 Pharmazeutische zusammensetzungen enthaltend dinoreburnamenine derivaten

Country Status (9)

Country Link
US (1) US5707651A (de)
EP (1) EP0729749B1 (de)
JP (1) JPH08325148A (de)
AT (1) ATE171618T1 (de)
CA (1) CA2170844A1 (de)
DE (1) DE69600702T2 (de)
DK (1) DK0729749T3 (de)
ES (1) ES2122767T3 (de)
FR (1) FR2731154B1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869500A (en) * 1996-12-13 1999-02-09 Hoffmann-La Roche Inc. Pyridone compounds useful in treating Alzheimer's disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2381048A1 (fr) * 1977-02-22 1978-09-15 Roussel Uclaf Nouveaux derives de 20,21-dinoreburnamenine, un procede pour leur preparation et leur application comme medicaments
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
FR2623501B1 (fr) * 1987-11-19 1990-03-16 Roussel Uclaf Nouveaux derives substitues de 20,21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les renfermant
IT8922398A0 (it) * 1989-11-16 1989-11-16 Phidea Spa Composizioni farmaceutiche ad elevato assorbimento e stabilita', comprendente una calcitonina come sostanza attiva.
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5178877A (en) * 1991-01-04 1993-01-12 Abbott Laboratories Encapsulated renin inhibitor composition

Also Published As

Publication number Publication date
FR2731154A1 (fr) 1996-09-06
EP0729749A1 (de) 1996-09-04
DK0729749T3 (da) 1999-06-21
US5707651A (en) 1998-01-13
DE69600702T2 (de) 1999-04-01
ES2122767T3 (es) 1998-12-16
EP0729749B1 (de) 1998-09-30
DE69600702D1 (de) 1998-11-05
JPH08325148A (ja) 1996-12-10
FR2731154B1 (fr) 1997-05-09
CA2170844A1 (fr) 1996-09-04

Similar Documents

Publication Publication Date Title
DE69025104D1 (de) Thiazolderivate, Verfahren zur Ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
IL107426A0 (en) Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same
ATE218570T1 (de) Makrocyclische immunmodulatoren
ES2057959T3 (es) Derivados de tienopiridina y composiciones farmaceuticas que los contienen.
KR900003163A (ko) 시클로헥산 유도체
ES2126370T3 (es) Nuevos derivados de n,n'-di(aralquil)-n,n'-di(2-azaaralquil)alquilenodiamina y su utilizacion en unas composiciones farmaceuticas y cosmeticas.
HUT40126A (en) Process for producing 6,7-disubstituted-1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphtiridine-3-carboxylic acid derivatives and pharmaceutical compositions and food additives containing them
DE69600702D1 (de) Pharmazeutische Zusammensetzungen enthaltend Dinoreburnamenine Derivaten
FI941836A0 (fi) 3-deoksioligosakkaridit, menetelmiä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
DE3868013D1 (de) Thiazolderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
IL85822A (en) 7-alkanesulphonoamido-1,2,4,5-tetrahydro-3h-3-benzazepine derivatives,their preparation and pharmaceutical compositions containing them
ES2057802T3 (es) Nuevos derivados de 3-amino-cromano, procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE3265616D1 (en) Cephalosporin derivatives, their preparation and pharmaceutical compositions containing them
NO923603L (no) 3-cykloalkyl-propen-2-amid-derivater og farmasoeytiske preparater inneholdende disse som aktiv bestanddel
EE9800134A (et) Farmatseutiline kompositsioon intravenoosseks manustamiseks
IL119054A (en) Substituted 4H-pyrans their preparation and pharmaceutical compositions containing them
DK168284A (da) Troponderivater
DE3365781D1 (en) New 1,4-diaminocyclitol derivatives, processes for their preparation and pharmaceutical compositions containing them
KR850003711A (ko) 진통 작용을 지닌 피롤-3-카르복실산의 제조방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee